{"schema_version":"1.0","provider":{"name":"Silica Corpora","slug":"silica-corpora","url":"https://bilarna.com/provider/silica-corpora","logo":"https://static.wixstatic.com/media/d940cb_98a7527c31084b2382a8f1fd9e280681%7Emv2.png/v1/fit/w_2500,h_1330,al_c/d940cb_98a7527c31084b2382a8f1fd9e280681%7Emv2.png","description":"*In Silica Corpora we design the next generation of antibody therapeutics using generative AI. Our Platform MALI offers an unprecedented accuracy in antibody design, achieved through enormous sequence-based training datasets and exceptional capabilities for integrating project-specific in vitro data"},"capabilities":{"Biotech Drug Discovery":[{"name":"AI-Driven Therapeutic Development","url":"https://bilarna.com/services/biotech-drug-discovery/ai-driven-therapeutic-development"}],"Antibody Therapeutics":[{"name":"De Novo Antibody Design","url":"https://bilarna.com/services/antibody-therapeutics/de-novo-antibody-design"}]},"trust":{"verified":true},"contact":{"profile_url":"https://bilarna.com/provider/silica-corpora","request_endpoint":"https://api.bilarna.com/api/agent/request?api-version=1.0"},"_links":{"self":"https://bilarna.com/provider/silica-corpora/agent.json","llms_txt":"https://bilarna.com/provider/silica-corpora/llms.txt","openapi":"https://bilarna.com/provider/silica-corpora/openapi.yaml","profile":"https://bilarna.com/provider/silica-corpora"}}